This review describes the clinical features that should suggest a search for systemic malignancy as the cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia.
James N. George, MD
Advertisement
Articles by James N. George, MD
Advertisement
Latest Updated Articles
- Systemic Malignancies as a Cause of Unexpected Microangiopathic Hemolytic Anemia and Thrombocytopenia
Published: September 15th 2011 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Amivantamab in EGFR+ NSCLC
2
FDA Grants Regular Approval to Rucaparib in Metastatic CRPC
3
Imlunestrant Combo Will Not Be Pursued for FDA Approval in Breast Cancer
4
Gathering Data to Ascertain Biomarker Specificity in HER2– Breast Cancer
5